Andrew Hykes - Mar 20, 2023 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
President and CEO, Director
Signature
/s/ Angela Ahmad, attorney-in-fact for Andrew Hykes
Stock symbol
NARI
Transactions as of
Mar 20, 2023
Transactions value $
-$578,610
Form type
4
Date filed
3/21/2023, 04:35 PM
Previous filing
Mar 14, 2023
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Sale -$462K -7.2K -1.28% $64.18 554K Mar 20, 2023 Direct F1, F2
transaction NARI Common Stock Sale -$117K -1.8K -0.32% $64.73 552K Mar 20, 2023 Direct F1, F3, F4
holding NARI Common Stock 1.55K Mar 20, 2023 By Child 1
holding NARI Common Stock 1.55K Mar 20, 2023 By Child 2
holding NARI Common Stock 1.55K Mar 20, 2023 By Child 3
holding NARI Common Stock 1K Mar 20, 2023 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022.
F2 This transaction was executed in multiple trades at prices ranging from $63.58 to $64.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $64.61 to $64.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 Balance includes 171 shares acquired under the Company's Employee Stock Purchase Plan.